Categories: News

Financière de Tubize – Annual Report 2022

FINANCIERE DE TUBIZE SA/NV

Allée de la Recherche 60, 1070 Brussels

Contact: eric.nys@financiere-tubize.be

Annual Report 2022

Regulated information
25 February 2023

The board of directors of Financière de Tubize has established the 2022 annual financial report. This report is available on the website www.financiere-tubize.be

  • Profit for the financial year: € 85.2 million (€ 83.6 million in 2021, +1,9%),
  • Increase of outstanding bank borrowings from € 20.0 million at 31 December 2021 to € 47.8 million at 31 December 2022,
  • Acquisition of 1,053,840 UCB shares, increasing the holding of the Company in UCB from 35.16% on 31 December 2021 to 35.70% on 31 December 2022.

If the general shareholders meeting of 28 April 2023 approves the 2022 annual accounts, including the proposed result appropriation, a gross dividend of € 0.86 (compared to €0,75 for financial year 2021, an increase of 14,7%) will be payable as from 5th of May 2023 onwards at the offices, seats and branches of BNP Paribas Fortis, in exchange of coupon n° 18.

Ex-dividend                3 May 2023
Record date               4 May 2023
Payment date            5 May 2023

Staff

Recent Posts

PillSafe Spearheads Solutions to Opioid Crisis With Revolutionary Technology

Government and industry have tried and failed to stem the overdose epidemic for more than…

3 hours ago

The Assistance Fund Opens New Program for Post-Traumatic Stress Disorder

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Post-Traumatic Stress…

3 hours ago

eClinicalWorks EHR Receives HRSA Approval for UDS+ Submissions for Health Centers Nationwide

eClinicalWorks successfully completes UDS+ FHIR® synthetic testing and begins FQHC voluntary testingWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the…

6 hours ago

Health eCareers Publishes 2024 Job Seeker Trends Report

Report Reveals Key Factors Shaping the Healthcare Recruitment and Retention LandscapeNEW YORK, NY / ACCESSWIRE…

6 hours ago

Retired US Marine Colonel Finds Pain Relief with sam(R) Wearable Ultrasound Unit

Sustained acoustic medicine technology from ZetrOZ Systems eliminates veteran's severe knee pain without surgery or…

6 hours ago

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results

Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

8 hours ago